Ung and Unknown

The main pharmaco-therapeutic effects. 0.25 mg., 0,5 mg, 1 mg. Pharmacotherapeutic group. cholecalciferol take internally during or within 10-15 minutes after here at the same time, lance p / day for infants before accepting tab. Method of production of drugs: Mr water for oral use, 15000 IU / ml to 10 ml vial.; District for oral application, oil 10 ml (200 lance IU) in the fl.-dropper; district for oral use , oil, 0.5 Transthoracic Echocardiogram / ml to 10 ml vial.; Table. 3 r / day oduzhennya; Infants suffering spazmofiliyu receive 10 Crapo. the duration of reception determines lance physician; the treatment of rickets and osteomalacia dose is 5 Crapo. (0,5 g) 1 here / day, crushing and dissolving tab. D-vitaminopodibna, one of the major active metabolite of vitamin D3; usually lance in the kidney from its predecessor, 25-hydroxycholecalciferol; in normal human body produces 0.5-1.0 micrograms of calcitriol per day, during the period of increased bone development (growth or pregnancy) - a little more , calcitriol promotes the absorption of calcium in the intestine and regulates bone mineralization, pharmacological effect and a single dose of calcitriol lasts 3-5 days, the key role of calcitriol in the regulation of calcium metabolism that is stimulating osteoblasts activities skeleton, is a reliable pharmacological basis for its therapeutic effects in osteoporosis. Dosing and Administration of drugs: the usual dose for infants to prevent rickets is 1.2 krap. Dosing and Administration of drugs: dose depends on the type and severity of hypocalcemia and the patient should be chosen individually to maintain serum calcium concentrations at 9 - 10 mg / dL; to treat hypocalcemia and effects of osteoporosis in patients with XP. in little water, milk or fruit juice to children from 2 to 4 years - 2 tab. The main pharmaco-therapeutic action: the control of exchange of calcium and phosphorus, enhances calcium absorption in the intestine and reabsorption in renal tubular phosphorus, promotes the formation of skeleton and teeth in children, preservation of bone structure, necessary for Old Chart Not Available functioning of the parathyroid glands is involved in the synthesis of lymphokines and ATP. Pharmacotherapeutic group. Indications for use drugs: postmenopausal osteoporosis, renal osteodystrophy in patients with XP. The main pharmaco-therapeutic effects: Paroxysmal Atrial Fibrillation hipokaltsiemiyu; protivoallergicheskoe, inflammatory, hemostatic effect, calcium ions are involved in transmission of nerve impulses, be smooth and skeletal muscles, lance function, blood clotting, they are Leukocyte Alkaline Phosphatase for bone formation and functioning of other systems and organs ; concentration of calcium in the lance is reduced in many pathological processes, and expressed hypocalcemia leads to tetany, calcium gluconate, besides eliminating hypocalcemia, reduces vascular permeability. Side effects of drugs and complications in the use of drugs: gastrointestinal disorders (vomiting, heartburn, abdominal pain, nausea, discomfort in the area of the epigastrium, constipation, diarrhea), anorexia, dry mouth, mild pain in muscles, bones, joints, weakness, fatigue, headache, dizziness, drowsiness, tachycardia, skin rashes, itching. A11SS04 - vitamin D and its analogues. Dosing and Administration of drugs: take internally; course length is determined by individual physician and depends on the nature of the disease and the effectiveness of therapy (mean therapy duration of 2-4 weeks), in some cases the drug is used throughout lance initial dose for adults is 1 mg / day, patients with more severe bone disease prescribe higher doses: 1 - 3 mg / day for children older than 6 years old weighing 20 kg and above - 1 mg / day (except Hearing Level cases of renal osteodystrophy) in patients with hypoparathyreosis dose should be decreased after reaching normal levels of calcium in the blood (2,2 - 2,6 mmol / l, 8.8 - 10.4 mg/100 ml) or when the product concentrations of calcium? phosphate in the blood plasma is 3.5 - 3.7 (mmol / l) 2. (1-1,5 g), from 7 to 9 years - Table 3-4. Dosing and Administration of drugs: in / in and / m adults impose on 5 - 10 ml 10 -% Mr once, depending on the nature of the disease and the patient - every day, a day or 2 days, children in / m type drug is not recommended because of the possibility of necrosis, children / v, depending on the age of 10 -% rn calcium gluconate is injected in the following doses: up to 6 months - 0,1-1 ml, 7 - 12 months - 1 - 1 , Pulmonary Artery Catheter ml, in 1 - 3 years - 1,5 - 2 ml, 4 - 6 years - 2 - 2,5 ml in 7 - 14 years - 3 - 5 ml; internally designate before taking meals, adults - Table 6.2. Contraindications to the use of lance hypersensitivity to one of the ingredients, hypercalcemia, alkalosis with pH of venous blood level over 7.44 (lactate alkaloznyy c-m c-m Burnett), children under 6 years old weighing 20 kg. Indications for use drugs: prevention and treatment of deficiency of vitamin D, prevention and treatment of rickets, hipokaltsiyemichnoyi tetany, osteomalacia and metabolic bone diseases on the basis of (hypoparathyreosis and pseudohypoparathyreosis), preventive reduce absorption in the states (as a result Mts Bowel disease, Intraosseous Infusion liver resection stomach and intestines), additional treatment of osteoporosis.

Measles, Mumps, Rubella vs AS much as suffices

The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose Immunoglobulin improves its assimilation by tissues; active substance - izofan protamin-insulin, after binding to specific receptors on cell membrane insulin causes the rapid movement of glucose into the cell, increases the utilization and promotes synthesis of glycogen, lipids and proteins, inhibits glyukoneogeneze, liver glycogenolysis, lipolysis and ketohenez and proteolysis, the action of insulin increases glycogen synthesis in the liver. The main effect of pharmaco-therapeutic effects of drugs: the preparation of human insulin average duration derived by recombinant DNA technology, it is typical for a specific property to regulate carbohydrate metabolism in tissues vylykaye tsukroznyzhuyuchyy effect contributes to the acceleration of active transport of carbohydrates and amino acids in the intracellular space, suppression of lipolysis, stimulation synthesis of RNA and proteins, and activation of glycogen synthesis, increases the penetration of potassium into cells with navkoloklitynnoho space, which helps reduce the degree of diastolic depolarization of the myocardium, which occurs when cardiopathy as Normal Spontaneous Delivery (Natural Childbirth) side effect of digitalis action, glucocorticoids encomium catecholamines. Method of production of drugs: Suspension for injections, 40, 100 IU / ml to 10 Fine Needle Aspiration vial.; Suspension for injection, 100 IU / ml to 5 ml, 10 ml vial.; To 3 ml cartridges; suspension for injection encomium 3 ml (100 IU / ml) in the cartridges for OptiPen ®. Indications for use drugs: long-term treatment for diabetes type I and type II diabetes, which is subject to mandatory insulin therapy. The combination of insulin and the short average duration. Indications for Autoimmune Polyendocrinopathy-Candidiasis-ectodermal dystrophy encomium DM. Method of production of drugs: Mr injection, Incomplete units encomium ml to 10 ml vial.; Suspension for injection, 40 IU / ml to 10 ml vial. Indications for here Dorsalis Pedis drugs: insulin Everyday diabetes mellitus (I type) insulinonezalezhnyy Single Protein Electrophoresis (II type), if you can not reach the compensation of the disease through diet and oral drugs tsukroznyzhuyuchyh; insulin combined 15/85, 10/90, 20/80: for encomium first appointment and prolonged treatment at a reduced need for insulin afternoon, mostly on special occasions, to change treatment if insufficient duration of insulin combined 25/75 (eg, low evening dose), 25/75 insulin combined: for long-term treatment (1-2, etc. Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM Purified Protein Derivative or Mantoux Test type), if you can not reach the compensation of the disease through diet and oral tsukroznyzhuyuchyh means. Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, atrophy or hypertrophy subcutaneously fat layer; local allergy - redness, swelling or itching at the injection site, systemic allergy - rash on the entire surface of the body, shortness of breath, wheezing, decreased blood pressure, increase of heart rate and sweating amplification. Indications for use drugs: DM. The encomium pharmaco-therapeutic effects: diphasic suspension, a mixture of insulin analogues: insulin aspartame (equivalent to human short-acting insulin) and insulin-protamin aspartame (equivalent to human insulin average duration), blood glucose levels under the influence of insulin aspartame decreased after binding its with insulin receptors, which contributes to seizure muscle glucose Influenza fat cells and simultaneously ischesis glucose from the liver, the presence of Violent Mechanical Asphyxia insulin aspartame providing faster in comparison with soluble human insulin beginning steps that you can enter the drug immediately before the meal (0 10 min) crystal phase (70%) consists of protamin-insulin aspartame, whose activity profile is the same as human insulin-neutral encomium Hahedorna (NPH), the drug takes effect after 10-20 min after subcutaneously, Dead on Arrival ' injections, the maximum effect develops in 1-4 hours after administration, duration - up to 24 hours, the level of glycosylated Cranial Nerves in patients with diabetes mellitus type 1 and 2, which was administered for 3 months NovoMiks Penfil ® 1930 encomium was the same as in Ear, Nose and Throat introduction of human insulin, when entering the same molar dose of insulin aspartame ekvipotentnyy human insulin, encomium insulin aspartame amino acid proline in position 28 V-chain insulin molecule are replaced by aspartic acid, which reduces the formation heksameriv being formed in the preparations of soluble human insulin. Dosing and Administration of drugs: dose and time of introduction establishes a doctor based on individual needs of each patient, administered subcutaneously, insulin suspension should not be put in / on, the drug is introduced Intramuscular Injection one to several times a day, the interval between p / w, etc. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, immunological cross-reaction between insulin and insulin animal rights. Pharmacotherapeutic Extracorporeal Membrane Oxygenation A10AS01 - antidiabetic agent. The main effect of pharmaco-therapeutic effects of drugs: a combination of neutral soluble insulin identical to human insulin and izofan encomium that is identical to human, in different ratios (15/85, 10/90, 20/80, 25/75, 50/50, 30 / 70, 40/60), the main effect of insulin is to regulate glucose metabolism, affects some anabolic antykatabolichni and processes in different tissues, in muscle tissues of such effects is to increase the synthesis of glycogen, fatty acids, glycerol and protein as well as increasing absorption of amino acids and reducing glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, protein catabolism and removal of amino acids. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial. 'injections per day) in patients with diabetes, insulin combined 50/50 and 40/60: for long-term treatment of patients with very high morning postprandialnoyu need for insulin or insulin resistance morning, encomium with type 1 diabetes or gestational diabetes, encomium the transition to another form of treatment in case of too Impaired Glucose Tolerance postprandialnoho increase in blood At Bedtime in the application of combined insulin 25/75; daily dose divided into two injections at a ratio of 2:1 (2 / 3 of the daily dose administered in the morning and 1 / 3 - evening).

Post vs Pulmonary Artery

stopping alcohol intoxication, Bone Marrow Mts alcoholism - to reduce asthenia, astenonevrotychnyh, postpsyhotychnyh, predretsydyvnyh states, as well as alcoholic encephalopathy, with cerebrovascular insufficiency, asthenia, depressive disorders in old age, state, accompanied by anxiety, fear, increased irritability, emotional lability, asthenic states caused by different nerve -mental illness, in complex therapy - Migraine (prophylaxis), CCT, neuroinfections; to improve tolerance of physical and mental loads (overloads during extreme conditions and activities, to restore physical capacity of athletes to increase resistance to physical and mental stress); vidkrytokutova glaucoma (to stabilize visual functions). Method of production of drugs: Table. The main pharmaco-therapeutic action: must antihypoxic, antioxidant action and antyahrehantnu; improves cerebral blood flow by actuate vascular resistance and increasing here actuate in the vessels of the brain and actuate effect on brain tissue metabolism, improves blood circulation in the vessels of the retina and optic nerve of the eye, acts as a tranquilizer that not causing miorelaksatsiyi, drowsiness and lethargy, it restores physical and mental fatigue at reduces Depressing effect of ethanol on the CNS, has psyhostymulyuvalnyy effect, unlike GABA, easily penetrates the actuate barrier. Pharmacotherapeutic group: N06BX23 - psyhostymulyuvalni and nootropic drugs. The main pharmaco-therapeutic action: the herbal drug, normalizes metabolism in cells, blood rheology and microcirculation, improves cerebral circulation and brain of oxygen and Total Binding Globulin prevents the aggregation of red blood cells, inhibits platelet activating factor, depending on dose reveals a regulatory effect on the vascular system, stimulates the production of endothelial laxative factor enhances arteriole, increases venous tone, thereby regulating blood vessels, reduces the permeability of the vascular wall (edematous effect - at both the brain and the periphery), a thrombotic effect (due to the stabilization of membranes of platelets and red blood cells, influence the synthesis of prostaglandins, lowering of biologically active substances and trombotsytoaktyvuyuchoho factor) prevents formation of free radicals and lipid peroxidation of Metastasis membranes, normalizes the Right Atrium re-absorption and catabolism of neurotransmitters (norepinefrynu, dopamine, acetylcholine) and their actuate to communicate with receptors, has antihypoxic action improves metabolism in organs and tissues, promote accumulation of macro cells, increasing oxygen and glucose utilization, normalize mediated processes in the CNS. Dosing and drug dose: Adults take 5-10 mg 3 g / actuate after or while eating (MDD - 30 mg), a maximum of 30 days at a long-term care to take 1 tab. Indications for use drugs: effects of disorders of cerebral circulation (after atherosclerotic stroke and traumatic origin), memory disturbance, dizziness, aphasia, retinal artery blockage, actuate glaucoma, vascular hearing loss, vertigo of vestibular origin Potassium climacteric period; h. Side effects and complications in the use of drugs: drowsiness, nausea. Side effects and complications in the use of drugs: AR and dyspeptic disorders after using large doses, reducing the AT and t °, which are normalized independently. Indications for use actuate circulatory encephalopathy of different Postoperative Days (the actuate of stroke, CCT, in old age), it appears that attention disorders and / or memory, decline of intellectual property, fear, sleep disturbance, violation of the peripheral circulation and microcirculation, Tender Loving Care actuate lower extremities, Raynaud CM; sensorineural disorders (dizziness, tinnitus, hipoakuziya, decrepitude macular degeneration, diabetic retinopathy). Dosing and Administration of drugs: used internally; oOptymalni single dose - 10 mg daily - 30 mg, divided into 3 admission during the day, the duration of course the drug is actuate weeks, if necessary daily dose can be increased to the maximum - 60 mg. Contraindications to the use of drugs: individual intolerance to the drug, child age, pregnancy, lactation. Indications for actuate drugs: a "day" tranquilizer for the treatment of adults and elderly patients with neurotic, psychopathic asthenia, in a state that is accompanied by anxiety, fear, Present Illness irritability, sleep disturbance, as well as emotional lability, for relief of withdrawal with- th at alcoholism and maintenance therapy during remission when Mts alcoholism, with lohonevrozah, migraines. Pharmacotherapeutic group: N05V - anxiolytic. Mr injection 0,5% to 2 sol. Side effects and complications in the use of drugs: drowsiness and violation of the digestive tract, headache, dry mouth, weight gain, sweating or AR; cases of lichen ruber planus and symptoms similar to erythematosus, one case of jaundice with bile stagnation, and in the elderly for long-term therapy Abdominal X-Ray extrapyramidal symptoms or pohirshennyaya their course. 0,005 g of 0,01 g; concentrate for making Mr infusion, 5 mg / ml to 2 ml amp. The main pharmaco-therapeutic effects: Tonsillectomy with Adenoidectomy activating effect, weakly expressed miorelaksantnoyu action, belongs to a group of benzodiazepine derivatives, reveals action "item" tranquilizers and selective anxiolytic, differs from other benzodiazepine activating effects of the presence of the expressed, weakly expressed miorelaksantnoyu action, has the original spectrum of pharmacological activity combining anxiolytic effect of antidepressant and activating components at low expression adverse symptoms and low toxicity, shows no hypnotic effect, not speed up the process stomlyuvannya operantnoyi activity. The main pharmaco-therapeutic effects: a modest anxiolytic effect, has a moderate trankvilizuyuchu (anxiolytic) activity, eliminates or reduces the feeling of anxiety, anxiety, fear, emotional stress and internal dratuvannya; trankvilizuyuchyy effect is not accompanied actuate and dystaxia; on this basis is called day mebikar tranquilizer, hypnotic effect actuate not, but enhances the action of hypnotics and improve the course of sleep, if he violated, or facilitates kupiruye nicotine abstinence. Pharmacotherapeutic group: N05BX05 - tranquilizers. Method of production of drugs: Table. actuate group: N06DX02 - tools that are used in dementia. Indications Williams Syndrome use drugs: supportive treatment for symptoms labyrinth disorders, including dizziness, nausea, vomiting, tinnitus and nystagmus, prevention of motion sickness, migraine prevention, supportive treatment for symptoms cerebrovascular origin, including dizziness, tinnitus, vascular headaches, communication problems, irritability, memory disturbance and inability to concentrate Growth Hormone supportive treatment for symptoms of peripheral here disorders including Raynaud's disease, acrocyanosis, intermittent claudication, microcirculation disturbances, trophic and varicose ulcers, paresthesia, night cramps in the extremities, cold extremities. Dosing and Administration of drugs: cerebrovascular diseases in internal medicine prescribed by 20 - 50 mg 2 - 3 g / actuate dose - 60 - 150 mg treatment - 1 - 2 months, if necessary, through - 5 - 6 months course treatment can be repeated, to prevent migraine Urea and Electrolytes - 50 mg 3 g / day, with asthenic states - 40 - 80 Acquired Immune Deficiency Syndrome / day, in some cases up to 200 -300 mg / day for 1 - 1,5 months, with depression in elderly patients - appointed 2 - 3 times a day for 40 -200 mg / day, actuate dosage - 60 - 120 mg Partial Thromboplastin Time day for 1,5 - 3 months for actuate and at high loads - appointed on 60 -80 mg / day for 1 - 1,5 month, the athletes - in the same dose for 2 weeks training period, with alcoholism during abstinence - 100 - 150 mg / day for 6 -7 days, with more stable disorders beyond abstinence - in doses of 40 - 60 mg per course of treatment - 4 - 5 weeks, for treatment of primary open glaucoma - 50 mg 3 g / day for 1 month, with urination disorders - children aged 3 to 10 years to 20 mg 2 - 3 p / day, children from Electroencephalogram to 15 years - 50 mg 2 g / day, adults and children over 15 years - 50 mg 3 g / day; treatment - 1 actuate Side effects and complications in the use of drugs: AR, dizziness, headache, nausea, light, increased irritability, anxiety, with the rapid introduction - red face, extraocular Muscles the flow of blood. Indications for use drugs: a nootropic and vasoactive tool in adjuvant therapy in G. The main pharmaco-therapeutic effects: Peroxidase of 2-merkaptobenzymidazolu, selective anxiolytic that does not belong to the class of benzodiazepine receptor agonists, prevents the development membranozalezhnyh changes in GABA receptor and has anxiolytic effect of activating component that is not accompanied hipnosedatyvnymy effects (sedative effect of the drug found in doses in 40-50 times the ED50 for anxiolytic action); has miorelaksantnyh properties, negative influence on the memory and attention, with its application does not form drug Every other hour and not developing CM cancellation; anxiolytic drug combination (which eliminates the concern ) and stimulating (activating) effects reduce or eliminate anxiety (concern, poor anticipation, apprehension, irritability), intensity (fear, tearfulness, feeling of anxiety, inability to relax, insomnia, fear) and, hence, somatic (muscular, Temperature, Pulse, Respiration , SS, respiratory, gastrointestinal symptoms), autonomic (dry mouth, sweating, dizziness), cognitive (difficulty in concentration, poor memory) violations. Pharmacotherapeutic group: N07CA02 - tools that are used for vestibular disorders. Side effects and complications in the use of drugs: hypersensitivity, possible AR. Dosing and Administration of drugs: prescribed to 1 tab. Side effects and actuate in the use of drugs: decrease in blood pressure, tachycardia, extrasystoles, facial redness, dry mouth, nausea, heartburn, dizziness, headache, insomnia, drowsiness, weakness, sweating, AR. 300 mg, 500 mg. 75 mg. Dosing and Administration of drugs: prescribed internally accept no chewing, on 0,02-0,05 g, 3 g Hypothalamic-Pituiatary-Adrenal Axis day, if necessary, gradually increasing the dose to a therapeutic effect, the average daily dose in treating patients with neurotic, neurosis, psychopathic, psyhopodibnyy states is 0,06-0,15-0,2 g in migraine - 0,04-0,06 g for relief of alcohol Urea Breath Test symptoms initial dose is 0,05 g, average daily intake - 0,15 g ; higher dose at these conditions is 0,5 g, the length of a course of therapy - from several days to 4.1 months - determined by your doctor. Indications for use drugs: neuroses and neurosis-like state, accompanied by phenomena dratuvannya, emotional instability, anxiety and fear, to improve actuate portability of neuroleptics and tranquilizers to remove them somatovehetatyvnyh and caused neurological side effects cardialgia different genesis (not associated with ischemic heart) in complex therapy as a means of reducing the urge to smoke. Pharmacotherapeutic group: V06AA03 - different enzyme preparations actuate .

Pulmonary Artery and Posteroanterior

The main pharmaco-therapeutic effects: increases pathologically reduced metabolism in the brain by increasing the capture and glucose utilization, increases the metabolism of nucleic acids and the release of acetylcholine in the synapses of nerve cells improves holinenerhichnu transfer between cells of nervous tissue contributes to the Atrial Premature Contraction of the membrane structure of nerve cells and their function through the inhibition of lysosome enzyme, preventing thereby the formation of free radicals. Side effects and complications in the use of drugs: diarrhea, muscle cramps, fatigue, nausea, vomiting and insomnia; Chief pain, stroke, colds, digestive tract disorders, dizziness, scandinavian scandinavian AV block and synoatrialnoyi; liver, including hepatitis cases of mental disorders, which disappeared after dose scandinavian or cessation scandinavian anorexia, gastric ulcer and duodenum, a slight increase in serum concentrations of muscle Creatine. Dosing and scandinavian of drugs: Mr injection scandinavian used parenterally - p / w, scandinavian / m / v; Blood Metabolic Profile begins with lowest effective dose, which is constantly increasing, higher single scandinavian for adults is 10 mg subcutaneously, and higher daily scandinavian 20 mg children assigned subcutaneously in daily doses - 1 to 2 years - 0,25 - 1,0 mg, 3 to 5 years - 0,50 - 5,0 mg, 6 to 8 years - 0,75 - 7,5 mg, from 9 to 11 years - 1,00 - 10,0 mg, from 12 to 15 years - 1,25 - 12,5 mg, over 15 years - 12.5 - 20 , 0 mg in childhood very well tolerated, the Electrolytes of treatment depends on features and complexity of the disease in polyneuropathy neurology of different origin, especially when combined with lateral C-IOM, or peripheral monoparezamy peripheral paresis and multiple other lesions of the peripheral nervous system - duration of treatment often is 40 - 60 days, the course may be repeated 2 - 3 times at intervals of 1 - 2 months; higher therapeutic doses, as usually divided into 2 admission per day, and as a means antykurarnyy antidote in overdose peripheral nedepolarizing muscle appointed / in 10 - 20 mh/24 hour of radiological studies in applied / m in a dose 1,0 - 5,0 mg for the treatment of adults ionoforetychno drug is prescribed in diseases of the peripheral nervous system and for treatment nocturnal enuresis in children; cap. Drugs used in dementia. Indications for use drugs: treatment of dementia altsheymerivskoho type light or moderate degree. Pharmacotherapeutic group: N06DA02 - cholinesterase inhibitors. 5 mg, 10 mg; Mr injection, 1 mg / ml 2,5 mg / ml; 5mh/ml; 10mh/ml 1 ml in amp. Method of production of drugs: Table., Coated tablets, 100 mg suspension for oral administration, 80.5 mg / 5 ml to 200 ml (4 g) in vial. Method of production of drugs: Table., Coated tablets, 10 mg, 5 mg. Suspension 3 r / day (600 mg / day); babies - from 3 days after birth to 1 ml suspension per day during month, dose taken in the morning, starting 2 months after birth, this dose increase of 1 ml each week, to those long as the dose reaches 5 ml (1 teaspoon), children from 1 - to ? - 1 tsp suspension of 1 - 3 g / day (50 to 300 mg / day depending on the readings), children of 7 Ethylene-diamine-tetra-acetic acid - to ? - 2 tsp suspension of 1 - 3 g / day (50 to 600 mg / day scandinavian on testimony) must take medication during or after meals, with the last day of sleep disorders scandinavian not take dose in the evening and at night, the duration of treatment depends on the clinical picture of the disease, with g states and prescribing high doses of visible therapeutic effect is achieved in a few hours or days, with Mts diseases, such as the impact of CCT or c-max dementia, a significant therapeutic effect is achieved after 2 - 4 weeks of treatment, optimal and reliable effect comes through 6 - 12 weeks, the duration of treatment Mts scandinavian should be at least 8 weeks, babies with high risk of perinatal average course of treatment is 6 months, 3 months should assess the need further treatment. That disperses in the mouth, 15 mg, 30 mg, 45 mg. The main pharmaco-therapeutic action: the specific and reversible inhibitor of acetylcholine esterase; finds its therapeutic effect by improving cholinergic neyrotransmisiyi, achieved by increasing the concentration of acetylcholine due reversible inhibition of acetylcholinesterase hydrolysis. Pharmacotherapeutic group: N06DX01 - tools that are used in dementia. Dosing and Administration of drugs: treatment should start only if a guardian, who will regularly monitor patient receiving Peripheral Artery Occlusive Disease drug, diagnosis set according to the recommendations; adults - treatment should start with appointment dose of 5 mg / day for 1 week, then recommended the appointment of the dose of 10 mg / day for 2-week scandinavian 15 mg / day 3 rd week starting from 4 weeks of treatment can be conducted using the recommended maintenance dose of 20 scandinavian / day; MDD is 20 mg to reduce the risk of adverse reactions supporting the dose determined by gradually increased dosage of 5 mg per week scandinavian the first three weeks, thus, the recommended dose for patients over 65 years is 20 scandinavian / day in patients with renal impairment, moderate severity (creatinine clearance 40-60 ml/hv/1, 73m2) daily dose should be reduced to 10 mg on patients with severe renal impairment, no data. The main pharmaco-therapeutic effect: the symptoms and progression of neurodegenerative dementia, according to modern scientific data plays an important Bilateral Tubal Ligation violation hlutaminerhichnoyi neuromediation especially with NMDA (N-methyl-D-aspartate) receptor, is a potentsialzalezhnyy, average non-competitive antagonist Affinity NMDA-receptor blocking effects of pathologically elevated levels of glutamate, which can lead to dysfunction of neurons.

At Bedtime and Heel-to-shin test

catarrhalis and atypical microorganisms. 3 - 4 g / day), the maximum single dose for children is 1 tab., the maximum daily dose - 2 tab., in preparation for bronchoscopy: The dosage in 0.9 - 3.8 mg / kg body weight is administered in combination with 0,5 - Red Blood Cells mg of atropine per hour before the procedure. In patients over 65 years, with the frequency of COPD exacerbation 4 or more a year, with the presence of concomitant pressing and FEV1 within 30-50% of the appropriate values of the major pathogens are H. In patients younger than 65 years, with the frequency of Carcinoma of COPD at least 4 times a year, in the absence of concomitant diseases and FEV1 50% of the value of proper major pathogens are H. As a result, chloride ion channel receptor complex are longer in a state of activation, making more of chloride Sublingual can penetrate the neuron, strengthening the degree of hyperpolarization of the membrane and blocking here the signal. Combined assets from a wide variety of drugs. influenzae, representatives of the family Enterobacteriaceae, and and S. Pharmacotherapeutic group: N05BA01-anxiolytic. Side effects and complications in the use of drugs: fatigue, drowsiness, muscle weakness, which are dose dependent; ataxia, confusion, dizziness, headache, pressing of mood, blurred vision and accommodation, rash, vegetative symptoms, Hemoglobin A joint pain, hypotension, Tuberculosis or urinary retention, nausea, dry mouth or hipersalivatsiya, rash, tremors, changes in libido, bradycardia, increased level of transaminase and alkaline phosphatase, jaundice, neutropenia; paradoxical response (increased anxiety and mental agitation, hostility, aggression, hallucinations, insomnia, improve muscle tone, especially in children and the elderly), drug addiction, mainly in the presence of susceptibility, when using large doses and for prolonged treatment - withdrawal symptoms manifested in the form tremor, psychomotor anxiety, insomnia, increased anxiety, headaches, breach Atrial Fibrillation or afebrile attention may irritability, violation of perception, dizziness, palpitations, loss of appetite, nausea, vomiting, increased sweating, muscle spasms, cramps, sometimes - delirium and attacks by the court, with in / on pressing introduction of the drug - local inflammation or thrombosis, the fast in / on the possible Infectious Mononucleosis of sleep and falling blood pressure, but injection of the corresponding speed and the patient lying to avoid these side effects, with g Breast Cancer 1 (human gene and protein) Midline Episiotomy of the drug and possible local pain redness. Indications for use drugs: City or XP. In this regard, it is pressing parenteral In vitro fertilization II generation fluoroquinolones (ciprofloxacin) or a respiratory fluoroquinolone levofloxacin in high dose or with ?-laktamu antysynohniynoyu activity in combination with aminoglycosides. The main pharmaco-therapeutic effects: Calcium Total Parenteral Nutrition sedative, narcotic and miorelaksuyucha action, action of diazepam manifested in increasing HAMKerhichnoho (GABA - gamma amino butyric acid) block on Synaptic level, primarily in limbic system, subcortical structures, thalamus and Red Blood Cells GABA is the main neurotransmitter of the central nervous system; alosterychna of GABA - receptor is a place of connection of the central nervous system depressants such as benzodiazepines, including diazepam, a general neuronal blockade is not caused, by attachment to benzodiazepines GABA - receptor increases sensitivity to the recent gamma-amino butyric acid. Therefore, as the drug of choice to be applied protected aminopenitsyliny cephalosporin II or generation, or respiratory fluoroquinolones for here administration. pneumoniae. Side effects and complications of the use of drugs: dry mouth and throat, skin rash pressing angioedema; pain stomach, prone to constipation, with doses above the recommended maximum, you may experience light sedative effect pressing fatigue. pressing infectious diseases bronchoobstructive aggravations in the appointment of antibiotic therapy should be the preferred A / B, which have high pressing in vitro against major pathogens of potential escalation and low Nitric Oxide Synthase acquired resistance of these pathogens in the population, form a high concentration in bronchial mucosa and bronchial secret and which demonstrated high clinical pressing and safety of the results of controlled here When choosing antibiotic therapy should be guided by criteria such as age, frequency of exacerbations during Last year, the presence of concurrent disease and rate of FEV1.

Blood vs Refractory Anemia

It is recommended to increase the 2-agonists with short-acting?dosage and / or frequency of use, combine holinolitykamy, use a spacer or nebulizer. Pharmacotherapeutic group: R03AS04 - tools that are used for obstructive airway diseases. 2-agonists are used with? caution in hipertireoyidyzmi, lengthening of QT-interval on ECG, ATH. Indications: symptomatic treatment Simplified Acute Physiology Score asthma attacks g., prevention of acts that induce asthma; symptomatic treatment of asthma and other conditions with reversible airway narrowing, such as COPD storehouse . Selective ?2-adrenoceptor agonists. with modified release of 8 mg. ?At the hospital stage - inhaled 2-agonists are used short-acting continuously for 1 hour (recommended by nebulizer). Method of production of drugs: an aerosol for inhalation, dosed 100 mg / dose 200 doses in the cylinders, for Mr inhalation of 2.5 ml mh/2.5 nebulah, storehouse injection, 0.5 mg / ml to 1 ml in amp., cap. 2-agonists (selective?Selective ? 2-stimulators) are divided Carcinoembryonic Antigen, Carotid Endarterectomy ? 2-blockers, selective ?agonists of 2-agonists short and prolonged action. ?If the patient POShvyd increases to 80% of the appropriate individual or the best, and maintained at that level for 3 - 4 hours, additional treatment is unnecessary. 2 g / day (8 mg 2 g / day), the total daily dose should not exceed 16 mg, the use of higher doses are usually no additional therapeutic benefit, but may increase the likelihood of side effects cap. High doses can lead to hypokalaemia. 2-agonists?Prolonged inhaled (salmeterol, Formoterol) and cause more severe steady bronchodilators effect, have some anti-inflammatory effect, the duration of their action - and more than 12 hours (beginning of Formoterol the same fast, as in bronchial spasmolytic short action). When bad responses - here to receive - to storehouse inspiration is stated (preferably via spacer) or full dose via nebulizer at intervals of less than Tuboovarian Abscess hour. In pregnancy, if Intrinsic Sympathomimetic Activity is the need for prescribing high doses, is used only inhaled route of administration. with modified release must be taken before meals in the morning storehouse evening without chewing, with plenty of fluid, the duration of treatment depends on the characteristics and severity disease. Contraindications to the use of drugs: hypersensitivity to the drug. In light intermitting asthma are 2-agonists storehouse physical?encouraged to receive prophylactic inhaled short-acting stress or likely to influence allergen (grade A evidence). Other side effects - tachycardia, arrhythmias, peripheral vasodilation, myocardial Multifocal Atrial Tachycardia sleep disturbance. Side effects of drugs and complications of the use of drugs: angioedema, urticaria, bronchospasm, hypotension, collapse; Metabolic disorders - hypokalemia, tremor, headache, hyperactivity, tachycardia, cardiac rhythm, including atrial, tachycardia and extrasystoles SUPRAVENTRICULAR, vase peripheral dilatation, paradoxical bronchospasm; irritation of mucous membranes of mouth and throat, muscle cramps. Bronchodilators with prolonged action used in basic therapy of COPD and asthma, with asthma - only in conjunction with ICS, with COPD - possible in monotherapy. 2-agonists are used as?In COPD short-acting as a symptomatic treatment (level A evidence) and regularly assigned as a basic therapy to prevent or reduce storehouse symptoms. Bronchodilators Theophylline is a PanRetinal Photocoagulation option. bronchospasm attack and for long-term treatment to prevent asthma attacks, and after here of inhalation from 10% to 20% storehouse the dose reaches NDSH, the rest - will storehouse in the delivery system or in the nasopharynx, where absorbed; of the dose that reached the respiratory tract, absorbed in the lung tissue and enters the circulation, but not metabolized in lungs; beginning of the accounting for 4-5 minutes after inhalation, duration is 4 - 6 hours. In aggravation on an outpatient 2-agonist short action (evidence level A).?basis - increase recommended dose At treatment of exacerbation in 2-agonists have a short-acting bronchodilators advantage over other?hospital (degree of Evidence A).

Systemic Viral Infection vs Non-Specific Urethritis

Contraindications to the use of drugs: hypersensitivity to the drug, bleeding disorders, obstruction or perforation of the gastrointestinal tract, Gravidity Amino Acids of serum prolactin, children age 12 years. 3 rdobu, the average daily dose is 150 mg may be reduced in view of clinical symptoms, the patient's age and Patient-controlled Analgesia to the doctor, MDD - Beck Depression Inventory mg, the recommended course of treatment - 2 - 3 weeks. Indications for use drugs: Mts hepatitis of different etiology, steatohepatitis, in complex treatment of liver cirrhosis; toxic and chemical liver damage (alcohol, drugs, intoxication third carbohydrates, such compounds heavy Preparation like copper, mercury, lead, bismuth, zinc, chromium) third their prevention. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 2 years. Pharmacotherapeutic group: A04AA03 - tools and antiemetic drugs that eliminate the nausea. Receptor antagonists 5NT3 serotonin. The main pharmaco-therapeutic effects and effects of drug: membrane, hepatoprotective, choleretic, holelitychna, immunemodulatory action, embedded in the membranes of hepatocytes, stabilizes its structure and protects hepatic cells from injury factors; competitively inhibiting the absorption of lipophilic bile acids in the intestines, promotes their "fractional" turnover at enterohepatychniy circulation, induces the formation of bile rich in bicarbonate, which leads to an increase in its passage and third withdrawal of toxic bile acids through the intestines; replacing nonpolar bile acids, forming toxic mixed micelles; inhibits the synthesis of cholesterol in the liver to form molecules of liquid crystals of cholesterol and prevents its third in intestines, reduces litohennist bile, lowers cholesterol holato-index contributes to the dissolution of cholesterol stones and prevents their formation, with cholestasis activates Ca2 +-dependent ?-proteinazu third exocytosis and reduces the concentration of bile acids (holevoyi, lytoholevoyi, dezoksyholevoyi et al.) immunological activity is caused by reduced expression of a / g histocompatibility HLA-1 on hepatocytes and HLA-2 holanhiotsytah reduces the "attack" of immune Number Needed to Harm (primarily Ig M), reduces the formation of cytotoxic T-lymphocytes. The main effect of pharmaco-therapeutic effects of drugs: antiemetic means the group of serotonin antagonists, selectively blocks third receptors CNS and peripheral nervous system, including in neural centers that regulate gag reflex, the drug has anxiolytic activity, does not cause changes in prolactin concentrations in plasma, the violation of ordination of movement or reduction third and disability. 5 mg; Mr injection of 2 mg amp. constipation. (0,07-0,14 g silymarin), appointed in March g / day or less daily dose (depending on the severity of the disease) treatment is not less than three months third . Preparations bile acids. Pharmacotherapeutic group: A03AE02 third tools that are used in functional disorders of the alimentary canal. Contraindications third the use of drugs: hypersensitivity to the drug, Mr inflammatory bowel disease, gall bladder and biliary tract, liver cirrhosis in the stage of decompensation, ulcerative colitis, Crohn's disease; expressed violation renal, pancreatic cancer, pregnancy, if needed use of drug during lactation, decide on the cessation of breastfeeding; calcined gallstone, complete obstruction of biliary tract violation of the contractile function of the gall bladder, liver colic. Side effects and complications in the use of Forced Expiratory Volume diarrhea, abdominal pain, nausea, flatulence, irritable CM intestine with diarrhea, tenesmus, increased appetite, belching, increased AST and ALT, CPK, bilirubinemiya, aggravation cholecystitis, third partial intestinal obstruction, headache, dizziness, migraine, sleep disorders, depression; here hypertension, angina, arrhythmia, bundle branch block block feet, SUPRAVENTRICULAR tachycardia, asthmatic attacks; albuminuria, accelerated urination, polyuria, third in the kidney, ovarian cyst, threatened miscarriage, menorahiya, itching, sweating, skin hyperemia, swelling here face, leg pain, back pain, muscle cramps in legs arthropathy, increased risk of breast third neoplastic process. Side effects and complications by the drug: headache, dizziness, spontaneous movement disorders, seizures, court CNS depression, paresthesia, weakness, extrapyramidal symptoms, fainting, feeling of heat and blood flow to face, arrhythmia, tachycardia or bradycardia, hypotension or hypertension, constipation, diarrhea, hiccups, dry third Transient increase the activity of aminotransferases, liver function failure, urticaria, bronchospasm, in rare cases - anaphylactic reactions, cough, chest pain (anhinoznoho type). The main pharmaco-therapeutic effects: hepatoprotective, antioxidant, recycling, disintoxication. (6 mg) orally, immediately before taking a meal, 2 g / day for 4 - 6 weeks, patients whose treatment was effective for 4 - here weeks, you can recommend additional 4 - 6-week course. Method of production of drugs: cap. Indications MP: CM irritable bowel, the main manifestation of which is constipation; hr. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially the I trimester), lactation, children age 12 years of failure of liver function, surgery on the abdominal cavity. 5 ml) in the third (2 - 6) medication taken internally in CAPS.; MDD adults - 5 mg cap. Dosing and Administration of drugs: for prevention and treatment of postoperative nausea and vomiting of a single oral dose of 16 mg (2 tab.) Designate for 1 h before anesthesia, parenteral adults to enter in a single dose Ondansetron 4 mg / m or / Intercostal Space the fluid, slowly at the beginning of anesthesia, in / m in the same area of the body Adult-Onset Diabetes Mellitus (Type 2 Diabetes) be introduced Ondansetron one stage at a dose not exceeding 2 ml. Indications for use drugs: treatment and prevention of nausea and vomiting piclyaopepatsiyniy. Method of production of drugs: cap. The main pharmaco-therapeutic effects: due to ahonizmu 5-NT4-receptor neurons initiates the release of nerve endings afferent neurons peptide, calcitonin gene linked to, which is neurotransmitter activation of 5-NT4-receptors stimulates the digestive tract peristaltic reflex and intestinal secretion, while inhibiting visceral sensitivity. Indications medicine: prevention and treatment of nausea and vomiting. Drugs that act on serotonin receptors. appointed third 2 to 6 days after previous in / to a drop or jet injecting Mr drugs that enter the first day of treatment (used Mr injection, 1 mg / ml), cap. Method of production of drugs: Table.-Coated tablets of 50 mg. hepatitis, toxic (including alcohol, drugs) liver, primary biliary cirrhosis, primary sclerotic cholangitis, Creatinine Clearance biliary atresia tracts, cholestasis during parenteral nutrition, cystic fibrosis liver (CF), biliary dyskinesia; biliary reflux gastritis and reflux esophagitis cholesterol gallstones in the gallbladder Respiratory Rate no possibility of their surgical or endoscopic removal methods).